Poolbeg Pharma #POLB CEO Jeremy Skillington talks to BRR Media and outlines the progress made in the 5 months post IPO, along with group plans for 2022.
Continue readingOpen Orphan PLC’s (LON:ORPH) Cathal Friel speaks to Rosie Riall at BRR Media after signing a new deal with a US biotech for the provision of a respiratory syncytial virus human challenge study. Cathal also covers the channel pipeline, the hVIVO quarantine centre, flu and malaria vaccines and the planned departure of CEO Trevor Phillips.
Continue readingCathal Friel & hVIVO Chief Scientist Andrew Catchpole discuss recent developments and the Coronavirus Challenge Study and the FLU-V Vaccine with the BRR Media team.
Continue readingCathal Friel, Executive Chairman of Open Orphan, provides an update on developments at the company following the successful fundraising, and also introduces Professor John Oxford – a leading expert in the field of virology and an original founder of hVIVO – who will be working with the company as a consultant.
Continue readingBRR Media interviews Cathal Friel, CEO of Open Orphan #ORPH. Click on the logo to listen.
Continue reading
